a procedureKidney transplant

A kidney from a living or a deceased donor is placed in the recipient's lower abdomen and plumbed into the iliac vessels and the bladder; the recipient's own kidneys are usually left in place. It replaces dialysis rather than curing the disease that destroyed the kidneys, and it commits the recipient to immunosuppressant drugs and monitoring for as long as the graft works. A living donor has a healthy organ removed and gains nothing clinically by it.

Two people are operated on, and only one of them is ill. That is what makes this the hardest subject in cross-border care, and it is why the law, rather than the price, is the first thing on this page.

The standing international statement is the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, agreed by 151 participants in Istanbul in April 2008, published in The Lancet on 5 July 2008 and revised in Madrid in July 2018. Its definitions do the work. "Travel for transplantation is the movement of persons across jurisdictional borders for transplantation purposes." It "becomes transplant tourism, and thus unethical, if it involves trafficking in persons for the purpose of organ removal or trafficking in human organs, or if the resources (organs, professionals and transplant centres) devoted to providing transplants to non-resident patients undermine the country's ability to provide transplant services for its own population." Organ trafficking, in the same text, covers "removing organs from living or deceased donors without valid consent or authorisation or in exchange for financial gain or comparable advantage to the donor and/or a third person", and also the soliciting or recruiting of donors or recipients "where carried out for financial gain or comparable advantage". Crossing a border for a transplant is not, by that text, wrong in itself. Buying the organ is.

The World Health Organization says the same thing as a rule rather than a definition. Guiding Principle 5, endorsed by the Sixty-third World Health Assembly in May 2010: "Cells, tissues and organs should only be donated freely, without any monetary payment or other reward of monetary value. Purchasing, or offering to purchase, cells, tissues or organs for transplantation, or their sale by living persons or by the next of kin for deceased persons, should be banned." The same principle permits "reimbursing reasonable and verifiable expenses incurred by the donor, including loss of income", which is the line every national statute has to draw somewhere.

National law then diverges, and it diverges on two separate questions. Whether a non-resident may be transplanted at all, and whether a living donor unrelated to the recipient may donate. Some countries permit both under conditions — an authorisation committee, a documented relationship, a ministry approval. Some permit transplantation of residents only. Commercial purchase is prohibited nearly everywhere: in the United States the National Organ Transplant Act makes it "unlawful for any person to knowingly acquire, receive, or otherwise transfer any human organ for valuable consideration for use in human transplantation if the transfer affects interstate commerce", while excluding from valuable consideration the reasonable costs of removal, transport and storage and the donor's "travel, housing, and lost wages". The country-by-country reading, one named instrument and one date at a time, sits on this directory's transplant prohibition page.

On scale, the figure most often repeated comes from the Declaration's own preamble, and it is old: "In 2007 it was estimated that up to 10% of transplants worldwide involved such practices", citing a provisional picture assembled by Shimazono in the Bulletin of the World Health Organization. It was a reconstruction from fragmentary reporting, its author said so, and nothing better has replaced it here.

General anaesthesia, three to five hours, and a ward stay that is short by the standards of major surgery: Milliman's 2025 estimate of the average US hospital stay is 7.5 days, against 20.2 for a liver. Immunosuppression starts at once and does not stop. Rejection is commonest early; infection is the price of the drugs that prevent it. What the published literature records about grafts obtained abroad through commercial routes is worse on every axis. A Riyadh centre compared 60 patients who had been transplanted abroad with 254 transplanted locally between January 2015 and December 2018: delayed graft function 18.3% against 6.3%, acute rejection 40% against 7.9%, and graft failure at three years 11.7% against 0.8%, with "higher posttransplant infection in general" and more urological complications. The US Centers for Disease Control's account of what travels with the patient is that donors "might not be screened as thoroughly", that organs "might be obtained using unethical means", and that recipients "may not receive adequate follow-up, including documentation from their surgeons". A transplant with no operative note is a lifelong medical problem for whoever inherits the patient.

The only price read for this record on 16 September 2026 is an American actuarial estimate. Milliman puts average 2025 US billed charges for a kidney transplant at 446,800 dollars across the window from 30 days before admission to 180 days after discharge, of which procurement — recovering, preserving and transporting the organ — is 135,400 and the transplant admission itself 142,500. The report states that billed charges "are unlikely to equal the actual amount paid". No hospital price for a self-paying foreign recipient was read here, and a price quoted for an operation whose second participant is a living donor is not a comparable object in any case.

This page describes an operation and reports what published instruments and studies say about it. It is not medical advice and it is not legal advice, and it does not say what any reader should do.